Iron chelators target both proliferating and quiescent cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Iron chelators target both proliferating and quiescent cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-07
DOI
10.1038/srep38343
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors
- (2015) Xiaonan Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Three-Dimensional Cell Culture-Based Screening Identifies the Anthelmintic Drug Nitazoxanide as a Candidate for Treatment of Colorectal Cancer
- (2015) W. Senkowski et al. MOLECULAR CANCER THERAPEUTICS
- Targeting cancer by binding iron: Dissecting cellular signaling pathways
- (2015) Goldie Y.L. Lui et al. Oncotarget
- 3D high-content screening for the identification of compounds that target cells in dormant tumor spheroid regions
- (2014) Carsten Wenzel et al. EXPERIMENTAL CELL RESEARCH
- Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
- (2014) Kıvanç Birsoy et al. NATURE
- Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
- (2014) Andrea Viale et al. NATURE
- Jaguar: A high-performance quantum chemistry software program with strengths in life and materials sciences
- (2013) Art D. Bochevarov et al. INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY
- Anti-mitochondrial therapy in human breast cancer multi-cellular spheroids
- (2012) Edna Ayerim Mandujano-Tinoco et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome
- (2012) Mohammed A. Aleskandarany et al. BREAST CANCER RESEARCH AND TREATMENT
- Mitochondria-Targeted Drugs Synergize with 2-Deoxyglucose to Trigger Breast Cancer Cell Death
- (2012) G. Cheng et al. CANCER RESEARCH
- Mitochondria “fuel” breast cancer metabolism: Fifteen markers of mitochondrial biogenesis label epithelial cancer cells, but are excluded from adjacent stromal cells
- (2012) Federica Sotgia et al. CELL CYCLE
- An anticancer agent, pyrvinium pamoate inhibits the NADH–fumarate reductase system—a unique mitochondrial energy metabolism in tumour microenvironments
- (2012) Eriko Tomitsuka et al. JOURNAL OF BIOCHEMISTRY
- Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment
- (2011) Joachim Gullbo et al. BIOCHEMICAL PHARMACOLOGY
- Antitumor Activity of Metal-Chelating Compound Dp44mT Is Mediated by Formation of a Redox-Active Copper Complex That Accumulates in Lysosomes
- (2011) D. B. Lovejoy et al. CANCER RESEARCH
- Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ
- (2011) Diana Whitaker-Menezes et al. CELL CYCLE
- Identification of Agents that Induce Apoptosis of Multicellular Tumour Spheroids: Enrichment for Mitotic Inhibitors with Hydrophobic Properties
- (2011) Walid Fayad et al. Chemical Biology & Drug Design
- Metformin Amplifies Chemotherapy-Induced AMPK Activation and Antitumoral Growth
- (2011) G. Z. Rocha et al. CLINICAL CANCER RESEARCH
- Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer
- (2011) G S Coombs et al. ONCOGENE
- Mitochondrial inhibitors show preferential cytotoxicity to human pancreatic cancer PANC-1 cells under glucose-deprived conditions
- (2010) Isao Momose et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Quantitative proteomics study of breast cancer cell lines isolated from a single patient: Discovery of TIMM17A as a marker for breast cancer
- (2010) Xiaoen Xu et al. PROTEOMICS
- High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer
- (2010) Mohamed Salhab et al. Breast Cancer
- Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells
- (2009) Y. Eberhard et al. BLOOD
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Iron Chelator-Mediated Alterations in Gene Expression: Identification of Novel Iron-Regulated Molecules That Are Molecular Targets of Hypoxia-Inducible Factor-1 and p53
- (2009) F. Saletta et al. MOLECULAR PHARMACOLOGY
- The fluorometric microculture cytotoxicity assay
- (2008) Elin Lindhagen et al. Nature Protocols
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started